Skip to main content Skip to main navigation menu Skip to site footer
Monaldi Archives for Chest Disease

Editor-in-Chief:A. Spanevello, Italy | eISSN 2532-5264 | pISSN 1122-0643

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
  • Copyright
  • Register
  • Login
  • Search
  • Contacts
  • News
0.8
Impact Factor
1.8
CiteScore
This journal has not published any issues.
0.8
Impact Factor
1.8
CiteScore
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Treatment of very old patients with non valvular atrial fibrillation. The valuable opportunity offered by New Oral Anticoagulants, to be cautiously used

    Francesco Orso, Riccardo Barucci, Stefania Fracchia, Giulio Mannarino, Alessandra Pratesi, Francesco Fattirolli
    2013-12-30
    https://doi.org/10.4081/monaldi.2013.17
    2226
    Downloads: 1179
  • Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials

    Stefania Angela Di Fusco, Furio Colivicchi, Nadia Aspromonte, Marco Tubaro, Alessandro Aiello, Massimo Santini
    2017-05-18
    https://doi.org/10.4081/monaldi.2017.805
    3067
    Downloads: 1433
  • Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation

    Giuseppe Patti, Ludmilla Mantione, Edoardo Bressi, Antonio Bisignani
    2018-06-07
    https://doi.org/10.4081/monaldi.2018.958
    4931
    Downloads: 1042
  • Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk

    Maurizio Giuseppe Abrignani, Furio Colivicchi
    2015-11-25
    https://doi.org/10.4081/monaldi.2013.80
    1591
    Downloads: 910
  • Net clinical benefit of anticoagulation therapy in the elderly patients with atrial fibrillation

    Lorenzo Palleschi, Eleonora Nunziata
    2018-06-07
    https://doi.org/10.4081/monaldi.2018.961
    4261
    Downloads: 852
  • Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: hemorrhagic risk and guidelines recommendations

    Maurizio Giuseppe Abrignani, Vincenzo Abrignani
    2015-11-25
    https://doi.org/10.4081/monaldi.2013.72
    1505
    Downloads: 780
  • Rivaroxaban in non valvular atrial fibrillation: subgroups analysis

    Cesare Greco
    2015-08-19
    https://doi.org/10.4081/monaldi.2014.37
    1628
    Downloads: 1082
  • Critical issues in megatrials on new oral anticoagulants. Rocket AF: applying results to low risk patients

    Massimo Uguccioni, Cosimo Napoletano
    2015-11-25
    https://doi.org/10.4081/monaldi.2013.85
    1265
    Downloads: 796
  • From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?

    Furio Colivicchi
    2015-11-25
    https://doi.org/10.4081/monaldi.2013.78
    1054
    Downloads: 862
1 - 9 of 9 items
Make a Submission

authors

FOR AUTHORS
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Index of Authors

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Keywords

Categories

    • Recent contents

indexing

INDEXING
  • PubMed
  • SCImago
  • Scopus
  • Web of Science
  • DOAJ
  • ESCI
  • OpenAlex
  • Scilit
  • Analytics
Monaldi Archives for Chest Disease

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 1122-0643
eISSN: 2532-5264

Info

  • About
  • Editorial Board
  • News
  • Advertising

Submissions

  • Submission
  • Guidelines For Authors

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.